Predictive value of STMN1 gene promoter polymorphism (−2166T>C) in patients with advanced NSCLC treated with the combination of platinum compounds and vinorelbine

PURPOSE: The combination of platinum compounds and vinorelbine is often used as a first-line treatment in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC), without activating EGFR mutations and ALK rearrangement. Unfortunately, less than half of the patients benefit fr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Chemother Pharmacol
Main Authors: Mlak, Radosław, Krawczyk, Paweł, Ciesielka, Marzanna, Homa, Iwona, Powrózek, Tomasz, Prendecka, Monika, Kozioł, Piotr, Milanowski, Janusz, Małecka-Massalska, Teresa
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2015
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4540763/
https://ncbi.nlm.nih.gov/pubmed/26220844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-015-2831-7
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki